fbpx
Medical Innovation Exchange

Thinning its $11B Array of options, Pfizer drops cardiology drug after phase 3 fails futility check

https://www.fiercebiotech.com/biotech/thinning-its-11b-array-options-pfizer-drops-cardiology-drug-after-phase-3-fails-futility

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.